Taltz
Active substance: ixekizumab
ixekizumab
Centralised EU authorisationActive
Marketing holder: Eli Lilly and Company (Ireland) Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 |
|
| US 4 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-cbe8-7860-9462-77048a4657ee,01a120c5-cafd-7f15-af58-fc17d00d2b6e;count=2 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-486e-711f-8e16-b3ff22c2f7c5,01a1208d-e913-707c-abef-8e690c9a699d,01a12095-708c-7b2e-9aa8-2b2b870c02bd,01a12095-7494-7da5-b07d-d69b8e34c177;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/003943
- Registration status
- Active
- ATC code
- L04AC13
Sources
- product · EMA · EMEA/H/C/003943 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/003943 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/003943 · Verified 2026-10-09